Outcomes in patients with tuberous sclerosis complex-associated treatment-refractory seizures, transitioning from placebo in core phase to everolimus during extension phase of the EXIST-3 trial

Lawson, J. A.; de Vries, P. J.; Curatolo, P.; Nabbout, R.; Polster, T.; French, J. A.; Ikeda, H.; Yapici, Z.; Franz, D. N.; Pelov, D.; Ridolfi, A.; Fan, J.; Voi, M.; Dlugos, D. J.

dc.contributor.author	Lawson, J. A.
dc.contributor.author	de Vries, P. J.
dc.contributor.author	Curatolo, P.
dc.contributor.author	Nabbout, R.
dc.contributor.author	Polster, T.
dc.contributor.author	French, J. A.
dc.contributor.author	Ikeda, H.
dc.contributor.author	Yapici, Z.
dc.contributor.author	Franz, D. N.
dc.contributor.author	Pelov, D.
dc.contributor.author	Ridolfi, A.
dc.contributor.author	Fan, J.
dc.contributor.author	Voi, M.
dc.contributor.author	Dlugos, D. J.
dc.date.accessioned	2021-03-04T08:19:18Z
dc.date.available	2021-03-04T08:19:18Z
dc.identifier.citation	French J. A. , Lawson J. A. , Yapici Z., Ikeda H., Polster T., Nabbout R., Curatolo P., de Vries P. J. , Dlugos D. J. , Voi M., et al., "Outcomes in patients with tuberous sclerosis complex-associated treatment-refractory seizures, transitioning from placebo in core phase to everolimus during extension phase of the EXIST-3 trial", 23rd World Congress of Neurology (WCN), Kyoto, Japonya, 16 - 21 Eylül 2017, cilt.381, ss.87
dc.identifier.other	vv_1032021
dc.identifier.other	av_62b65cb1-eae3-40b3-9368-3e895595c3c0
dc.identifier.uri	http://hdl.handle.net/20.500.12627/68735
dc.identifier.uri	https://doi.org/10.1016/j.jns.2017.08.293
dc.language.iso	eng
dc.subject	Dahili Tıp Bilimleri
dc.subject	Yaşam Bilimleri (LIFE)
dc.subject	Sinirbilim ve Davranış
dc.subject	NEUROSCIENCES
dc.subject	Klinik Tıp (MED)
dc.subject	Klinik Tıp
dc.subject	Temel Bilimler
dc.subject	Yaşam Bilimleri
dc.subject	Nöroloji
dc.subject	Tıp
dc.subject	Sağlık Bilimleri
dc.subject	KLİNİK NEUROLOJİ
dc.title	Outcomes in patients with tuberous sclerosis complex-associated treatment-refractory seizures, transitioning from placebo in core phase to everolimus during extension phase of the EXIST-3 trial
dc.type	Bildiri
dc.contributor.department	City University Of New York Brooklyn College , ,
dc.identifier.volume	381
dc.contributor.firstauthorID	152435

Bu öğenin dosyaları:

Dosyalar	Boyut	Biçim	Göster
Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Bildiri [64839]

Basit öğe kaydını göster